Komori
Sundrug (9989) · PolicyAdvanced

Reduction of cross-shareholdings and review by the Board of Directors

First written in FY2019. 3 of 5 entries say "Restated". Latest entry: FY2025.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20232019: 120192020: 020202021: 120212022: 120222023: 120232024: 020242025: 12025
Same theme, other companies
Verification of the Rationale for Holding Strategic ShareholdingsA theme 1606 companies write about · 1 as a headwind · 827 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1611 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「All shares in 株式会社コンコルディア・フィナンシャルグループ, Mizuho Financial Group,Inc., 株式会社三井住友フィナンシャルグループ and Resona Holdings, Inc. have been sold.」

    Regarding cross-shareholdings, all shares in the 4 financial institutions held in the previous fiscal year were sold, leaving 1 listed shareholding at the end of the current fiscal year. The company continues its policy of reducing such holdings and having the Board of Directors review them annually.
  2. FY2023RestatedAnnual report

    「The cross-shareholdings currently held are not reciprocal holdings. We intend to reduce them as appropriate, taking into consideration share prices, market trends and other factors.」

    The company continues its policy of reducing cross-shareholdings and having the Board of Directors review them annually against the cost of capital.
  3. FY2022RestatedAnnual report

    「The cross-shareholdings currently held are not reciprocal holdings. We intend to reduce them as appropriate, taking into consideration share prices, market trends and other factors. For each individual stock, the Board of Directors regularly reviews the rationale and necessity of continued ownership annually from a medium- to long-term perspective, comparing the expected returns with the cost of capital,」

    The company continues its policy of reducing cross-shareholdings and having the Board of Directors review them annually against the cost of capital.
  4. FY2021RestatedAnnual report

    「The cross-shareholdings currently held are not reciprocal holdings. We intend to reduce them as appropriate, taking into consideration share prices, market trends and other factors. For each individual stock, the Board of Directors regularly reviews the rationale and necessity of continued ownership annually from a medium- to long-term perspective, comparing the expected returns with the cost of capital,」

    The company continues its policy of reducing cross-shareholdings and having the Board of Directors review them annually against the cost of capital.
  5. FY2019First statedAnnual report

    「The cross-shareholdings currently held are not reciprocal holdings. We intend to reduce them as appropriate, taking into consideration share prices, market trends and other factors. For each individual stock, the Board of Directors regularly reviews the rationale and necessity of continued ownership annually from a medium- to long-term perspective, comparing the expected returns with the cost of capital,」

    The company stated for the first time its policy of reducing cross-shareholdings and its system of reviewing each individual holding annually against the cost of capital.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sundrug yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.